Findings support the Timed Up and Go (TUG) test combined with pain assessment as a promising functional endpoint for evaluating mobility ...

Portia Cina is an 18-year-old from New Jersey who wakes up every single morning and spends 45 minutes moisturizing her entire ...

In PEOPLE's exclusive clip from ‘One Day in My Body,’ Portia Cina, 18, shares her experience living with ichthyosis with ...

Acquisition adds high-payload herpes simplex virus (HSV) gene therapy targeting genetic skin diseases to LEO Pharma’s ...

Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the ...

Danish dermatology specialist Leo Pharma is paying $50 million for U.S. gene writing biotech Replay and its preclinical gene ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

Quoin Pharmaceuticals Ltd. has announced the filing of U.S. and International patent applications for new topical formulations of rapamycin aimed at treating rare diseases such as microcystic ...

FT Island's member Hongki recently opened up about his personal life and suffering from a rare skin condition that has managed to caused a lot of issues in his life. FT Island’s Hongki talked about ...

Findings support the Timed Up and Go (TUG) test combined with pain assessment as a promising functional endpoint for evaluating mobility impairment in palmoplantar epidermal differentiation disorders ...